Prescription drug · NDA
Durysta (Bimatoprost) NDC 0023-9652
Bimatoprost 10 ug/1 · Implant · Intracameral · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0023-9652-01 | 0002396520100023965201 | 1 IMPLANT in 1 POUCH (0023-9652-01)Marketed from Mar 4, 2020 | |
| 0023-9652-03 | 0002396520300023965203 | 1 IMPLANT in 1 POUCH (0023-9652-03)Marketed from Mar 4, 2020 · Sample package |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Durysta
- Generic name (nonproprietary)
- bimatoprost
- Active ingredients
- Bimatoprost — 10 ug/1
- Dosage form
- Implant
- Route
- Intracameral
- Labeler
- Allergan, Inc.NDC labeler code 0023
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 211911
- Marketing start
- Listing expires
- Other FDA classes
- Prostaglandins (Chemical structure)
- Identifiers
- Product ID 0023-9652_0315cd41-0cc8-44c3-82fc-501832cdb855SPL ID 0315cd41-0cc8-44c3-82fc-501832cdb855SPL set ID 3f59da84-0bcc-4c84-b3e2-e215681ef341RxCUI 2286602, 2286607UNII QXS94885MZ
- Pharmacologic class
- Prostaglandin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400023965201followed by a unit qualifier and the quantityPackage 00023-9652-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
DURYSTA ® (bimatoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT). DURYSTA is a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0023-9652
- What is NDC 0023-9652?
- 0023-9652 is the product NDC for Durysta (bimatoprost), Bimatoprost 10 ug/1 implant, listed with the FDA by Allergan, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Durysta (Bimatoprost).
- What is the active ingredient?
- Bimatoprost.
- Who is the labeler?
- Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Durysta?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.